Cytokines and HIV infection. Pathophysiology, diagnosis and therapeutic strategies;Cytokines et infection par le virus de l'immunodeficience humaine (VIH-1): Implications physiopathologiques et consequences diagnostiques et therapeutiques

Immuno-Analyse et Biologie Specialisee

Volumn 12, Issue 2, 1997, Pages 65-69

  Guenounou, M ^a  

^a NONE

Author keywords

cytokines; diagnosis; HIV 1; immune deficiency; infection; pathophysiology; therapy

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0030979881     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(97)88664-4     Document Type: Article

References (50)

1. Agosti JM, Coombs RW, Collier AC, Paradise MA, Benedetti JK, Jaffe HS et al. A randomized, double-blind, phase I/II trial of tumor necrosis factor and Interferon gamma for treatment of AIDS-related complex (protocol 025 from the AIDS Clinical Trials Group). AIDS Res Hum Retroviruses 1992; 8: 581-7
2. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995; 92: 4838-42
3. Ameisen JC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS 1994; 198: 360-5
4. Arya SK, Gallo RC. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV infection. Proc Natl Acad Sci USA 1996; 93: 4486-91
5. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection. Correlations to clinical, immunological and virologic parameters. J Infect Dis 1994; 169: 420-4
6. Autran B, Haasq G, Hadida F, Plikat U, Hosmalin A, Meyerhans A et al. Adaptation of the HIV specific CTL repertoire with disease progression. In: Guenounou M, ed. HIV and cytokines. Paris : Inserm, 1997 (à paraître)
7. Belec L, Gherardi R, Payan C, Prazuck J, Malkin JE, Tevi-Benissan C et al. Proinflammatory cytokine expression in cervicovaginal secretion of normal and HIV infected women. Cytokine 1995; 7: 568-74
8. Butera ST, Roberts BD, Critchfield JW, Fang G, Mc Quade T, Gracheck SJ et al. Compounds that target novel cellular components involved in HIV transcription. Mol Med 1995; 1: 758-67
9. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, Mc Gregor RR et al. Impaired Interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994; 179: 1361-6
10. Chermann JC. HIV regulatory genes and hematopoiesis. In: Guenounou M, ed. HIV and cytokines. Paris: Inserm, 1997 (à paraître)
11. Clerici M, Balotta C, Salvaggio A, Riva C, Trabattoni D, Pagano L et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996; 88: 574-9
12. Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-10
13. Clerici M, Lucey D, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP et al. Restoration of HIV-specific cell-mediated immune response by interleukin 12 in vitro. Science 1993; 262: 1721-4
14. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A et al. Role of interleukin 10 in T helper cell dysfunction in asymptomatic individuals infected with HIV. J Clin Invest 1994; 93: 768-77
15. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW et al. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994; 91: 11811-5
16. Cocchi F, De Vico AL, Garzino-Demo A, Arya SK, Gallo R. Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-5
17. Collette Y, Chang HL, Cerdan C, Chambost H, Algarte M, Mawas C et al. Specific Th-1 cytokine down regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene induced expression. J Immunol 1996; 156: 360-8
18. Daftarian MP, Diaz-Mitoma F, Creery WD, Cameron W, Kamur A. Dysregulation of production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative response to recall antigens. Clin Diagn Lab Immunol 1995; 2: 712-8
19. Delemarre FGA, Stevenhagen A, Snijders F, Kreoon FP, Van Eer MY, Reiss P et al. Restoration of toxoplasmastatic activity of monocytes from AIDS patients during in vivo treatment with interferon-gamma. J Infect Dis 1993; 168: 516-8
20. Del Prete G, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995; 16: 76-80
21. Deng H, Liu R, Ellmeier W et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661-6
22. Emilie D, Fior R, Liorente L, Marfaing-Koka A, Peuchmaur M, Devergne O et al. Cytokines from lymphoids organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol Rev 1994; 140: 5-34
23. Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay JY et al. Administration of an anti-interleukin 6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 1994; 84: 2472-9
24. Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM et al. T helper type 1/T helper type 2 cytokines and T-cell death: preventive effect of IL-12 on activation induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus infected persons. J Exp Med 1995; 182: 1759-67
25. Estaquier J, Tanaka M, Suda T, Goldstein P, Ameisen JC. FAS-mediated apoptosis of CD4+ T and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effects of cytokines and protease antagonists. Blood 1996; 87: 4959-66
26. Friedland JC. Chemokines and human infection. Clin Sci 1995; 88: 400-6
27. Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992; 6: 347-63
28. Goletti D, Kinter AL, Hardy EC, Poli G, Fauci AS. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. J Immunol 1996; 156: 3501-8
29. Gras G, Legendre C, Krzysieck R, Dormont D, Galanaud P, Richard Y. CD40/CD40L interaction and cytokines regulate HIV replication in B cells in vitro. Virology 1996; 220: 309-19
30. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected patients. Science 1994; 265: 248-52
31. Haynes BF, Pantaleo G, Fauci AS. Toward understanding of the correlates of protective immunity to HIV infection. Science 1996; 271: 324-8
32. Karsten V, Gordon S, Kirn A, Herbein G. HIV-1 envelope glycoprotein gp 120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumor necrosis factor. Immunology 1996; 88: 55-60
33. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT, Falloon J et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N Engl Med 1995; 332: 567-75
34. Mackewicz CE, Blackbourn DJ, Levy JA. CD 8+ cells supress HIV replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1997 (à paraître)
35. Maggi E, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Piccinni MP et al. Th2 like CD8+ T cells showing B cell helper function and reduced cytolytic activity in HIV type 1 infection. J Exp Med 1994; 180: 489-95
36. Maggi E, Mazetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferencially in Th2 and Th0 cells. Science 1994; 265: 244-9
37. Methali M, Leissner P, Calenda V, Sanhadji K, Marigliano M, Touraine JL. Gene therapy of AIDS: inhibition of viral replication by transfer of HIV-inducible genes. In: Guenounou M, ed. HIV and cytokines. Paris: Inserm, 1997 (à paraître)
38. Montaner LJ, Gordon S. TH2 down regulation of macrophage HIV-1 replication. Science 1995; 267: 538-9
39. Murray HW, Squires KE, Gassyuk-Botev E. Interleukin-2 treatment, interferon-gamma induction, and AIDS monocyte activation. Am J Med 1992; 93: 23
40. Puri S, Aggarwal BB. Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human lymphoid (H9) cell line. AIDS Res Hum Retroviruses 1995; 11: 31-40
41. Re MC, Furlini G, Zauli G, La Placa M. Human immunodeficiency virus type 1 (HIV-1) and heamatopoietic progenitors cells. Breif review. Arch Virol 1994; 137: 1-23
42. Romagnani S, Del Prete G, Manetti R, Ravina A, Annunziato F, De Carli M et al. Role of Thl/Th2 cytokines in HIV infection. Immunol Rev 1994; 140: 73-92
43. Smets P, Benbernou N, Kadio A, Bondurand P, Guenounou M. Overexpression of Th-1 and Th-2 Type cytokines in AIDS African patients and depressed IL-2 expression in HIV associated tuberculosis. In: Guenounou M, ed. HIV and cytokines. Paris: Inserm, 1997 (à paraître)
44. Squires KE, Brown ST, Armstring D, Murphy WF, Murray HW. Interferon-gamma treatment for Mycobacterium avium intracellular complex bacillemia in patients with AIDS. J Infect Dis 1992; 166: 686-7
45. Teppler H, Kaplan G, Smith KA, Cameron P, Montana A, Meyn P et al. Efficacy of low doses of the Polyethylene Glycol derivative of interleukin 2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J Infect Dis 1993; 167: 291-8
46. Trinchieri G, Pagani C, Frank I, Chechimi J. Interleukin 12 in the pathogenesis and therapy of HIV. In: Guenounou M, ed. HIV and cytokines. Paris: Inserm, 1997 (à paraître)
47. Wesch D, Kabelitz D, Freise K, Pechhold K. Mycobateria-reactive γ δ T cells in HIV-individuals: lack of Vγ 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells. Eur J Immunol 1996; 26: 557-62
48. Yawetz S, Cumberland WG, Van der Meyden M, Martinez-Maza O. Elevated serum levels of soluble CD 23 precede the appearance of acquired immunodeficiency syndrome-associated non Hodgkin's lymphoma. Blood 1995; 85: 1843-9
49. Zhang M, Gong J, Lyer DV, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94: 2435-42
50. Zouali M. B cell superantigens: implications for selection of human antibody repertoire. Immunol Today 1995; 16: 399-405